REQUEST A DEMO
Total
USD $0.00
Search more companies

Sankur Pharmaceuticals Private Limited (India)

Main Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Sankur Pharmaceuticals Private Limited Profile Updated: May 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sankur Pharmaceuticals Private Limited is an enterprise in India, with the main office in Agra. The enterprise currently operates in the Accounting, Tax Preparation, Bookkeeping, and Payroll Services sector. Sankur Pharmaceuticals Private Limited was incorporated on February 23, 2016. In its most recent financial highlights, the company reported a net sales revenue increase of 22.45% in 2024. Over the same period, its total assets decreased by 14.01%. In, 2024, the company’s net profit margin increased by 0.06%.

Legal Address
F-648 Kamla Nagar
Agra; Uttar Pradesh; Postal Code: 282005

Contact Details: Purchase the Sankur Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sankur Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Sankur Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
February 23, 2016
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Sankur Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
22.45%
Total Operating Revenue
22.34%
Operating Profit
26.7%
EBITDA
78.47%
Net Profit/Loss for the Period
26.43%
Total Assets
-14.01%
Total Equity
35.72%
Operating Profit Margin
0.1%
Net Profit Margin
0.06%
Return on Equity (ROE)
-1.44%
Debt / Equity
-12.31%
Quick Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?